STUDY THE PROGNOSTIC VALUE OF INFLAMMATORY BLOOD MARKER FOR OVERALL SURVIVAL IN NON-METASTATIC BREAST CANCER

Clinical Prognostic Factors in Breast Cancer

Prognostic Factors in Breast Cancer Patients with Brain Metastases: Retrospective Analysis

ASSESSMENT OF SURGICAL MANAGEMENT OF FEMALE BREAST CANCER PATIENTS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR INVASIVE DUCTAL VERSUS INVASIVE LOBULAR CARCINOMA (T3 STAGE)

Assessment of the Prognostic Role of Ki-67 and Its Optimal Cutoff Value in Early Breast Cancer: A Retrospective Analysis

THE PROGNOSTIC AND PREDICTIVE VALUE OF SERUM BONE BIOMARKER (CTX) IN PATIENTS WITH BREAST CANCER METASTATIC TO BONE RECEIVING ZOLEDRONIC ACID

Resection of The Primary Tumor in Patients with Metastatic Breast Cancer, Impact on Patients’ Survival, A Comparative Retrospective Study

SURVIVAL OF PREMENOPAUSAL BREAST CANCER PATIENTS IN RELATION TO MENSTRUAL TIMING OF SURGERY WITH PERITUMORAL ESTROGEN RECEPTOR STATUS AND ANGIOGENESIS

Assessment of prognostic value FOXA1 Expression in breast carcinoma after neoadjuvant chemotherapy: Immunohistochemically Study

ASSESSMENT OF GLANDULAR FLAP IN LEVEL I ONCOPLASTIC BREAST SURGERY IN FEMALE PATIENTS WITH BREAST CANCER